Showing results (21-30 of 176) with videos related to

Sort By:
Pageof 18
European Urology|February 5, 2003
Osteocalcin gene HindIII C/T polymorphism is a biomarker for prostate cancer and responsiveness to hormone therapyHsi-Chin Wu, Cheng-Chieh Lin, Wen-Chi Chen, et al.
Urology|August 2, 2003
Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancerCheng-Chieh Lin, Hsi-Chin Wu, Fuu-Jen Tsai, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|January 27, 2017
The percentage of resected and ischemic volume determined by a geometric model is a significant predictor of renal functional change after partial nephrectomyWei-Hsuan Huang, Chao-Hsiang Chang, Chi-Ping Huang, et al.
Journal of Diabetes and Its Complications|September 5, 2003
Using Tc-99m DMSA renal cortex scan to detect renal damage in women with type 2 diabetesHsi-Chin Wu, Chao-Hsiang Chang, Ming-May Lai, et al.
Endocrine Research|July 15, 2003
Lumbar bone mineral density in prostate cancer patients with bone metastasesChao-Hsiang Chang, Chang-Shu Tsai, Yick-Fung Jim, et al.
Journal of Clinical Laboratory Analysis|November 23, 2006
IL-2 gene C/T polymorphism is associated with prostate cancerHsi-Chin Wu, Chao-Hsiang Chang, Lei Wan, et al.
Biomaterials|May 19, 2009
The in vivo performance of biomagnetic hydroxyapatite nanoparticles in cancer hyperthermia therapyChun-Han Hou, Sheng-Mou Hou, Yu-Sheng Hsueh, et al.
Pageof 18